Simulating physiology and methods for therapeutic evaluation with emphasis on hypertension

Area of Science:

• Computational biology and bioinformatics.
• Medical simulation and artificial intelligence applications.

Background:

• Therapeutic advancements focus on enhancing diagnostic accuracy and treatment efficacy.
• Computational methods are established in interpreting medical imaging (MRI, CAT scans) and understanding biochemical structures for treatment development.

Purpose of the Study:

• To review the role of computer simulation in advancing therapeutic treatments, termed In Silico Biology.
• To explore the potential of simulation in clinical diagnosis and the development of novel therapeutic strategies.

Main Methods:

• Review of current applications of computer simulation in biological and medical contexts.
• Examination of how simulations of cells, organs (pulmonary, cardiovascular), and systems can aid clinical diagnosis.
• Discussion on the integration of simulation with artificial intelligence (AI) and experimental databases.

Main Results:

• Simulation can significantly improve diagnostic capabilities in clinical practice.
• The combination of In Silico Biology with AI and large experimental datasets yields powerful tools for medical research and practice.
• Simulation accelerates cost- and time-effective drug design and development.

Conclusions:

• Computer simulation, particularly In Silico Biology, offers a fundamental role in improving therapeutic treatments.
• AI integration is crucial for evaluating patient risk factors and predicting adverse drug effects, enhancing personalized medicine.
• While requiring refinement for general practice, simulation technologies hold immense promise for future healthcare.